Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation.

Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation. J Clin Oncol. 2020 09 10; 38(26):3032-3041.

View in: PubMed

subject areas

Aged
Disease Progression
Endpoint Determination
Humans
Kallikreins
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Recurrence, Local
Predictive Value of Tests
Prostate-Specific Antigen
Prostatic Neoplasms
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Time Factors

authors with profiles

James J. Dignam